ダウンロード数: 1707

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
55_187.pdf322.21 kBAdobe PDF見る/開く
タイトル: 前立腺特異抗原(PSA)軽度上昇症例におけるα1アドレナリン受容体遮断薬内服によるPSAの変化について: 前立腺肥大症/下部尿路症と前立腺癌の比較
その他のタイトル: The Changes of Prostate Specific Antigen (PSA) after Treatment with Alpha 1-Adorenergic Receptor Antagonists in Men with 4.0-9.9 ng/ml PSA Level: A Study for Comparison of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom (BPH/LUTS) and Prostate Cancer
著者: 花井, 禎  KAKEN_name
松本, 成史  KAKEN_name
小路, 直  KAKEN_name
臼井, 幸男  KAKEN_name
唐, 小燕  KAKEN_name
加藤, 良成  KAKEN_name
井口, 正典  KAKEN_name
植村, 天受  KAKEN_name
寺地, 敏郎  KAKEN_name
著者名の別形: Hanai, Tadashi
Matsumoto1, Seiji
Shouji, Sunao
Usui, Yukio
Tang, Xian Yan
Kato, Yoshinari
Iguchi, Masanori
Uemura, Hirotsugu
Terachi, Toshirou
キーワード: Prostate-specific antigen (PSA)
Alpha 1-adrenergic receptor antagonists (alpha 1 blockers)
Benign prostatic hyperplasia/lower urinary tract symptom (BPH/LUTS)
発行日: Apr-2009
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 55
号: 4
開始ページ: 187
終了ページ: 191
抄録: The aims of this study were to define the relationships between prostate-specific antigen (PSA) and alpha 1-adrenergic receptor antagonist (alpha 1 blocker). A prospective clinical study of 48 male patients examined between May 2004 and December 2007 was performed. 4.0-9.9 ng/ml PSA level who had no notable clinical findings of urinary retention, urinary tract infections and prostate cancer (PC) received tamusulosin 0.2 mgonce daily for 3 months, and then received prostate biopsy. We divided the patients into two groups : PC and benign prostate hyperplasia (BPH)/lower urinary tract symptom (LUTS) group. In total, the PSA level showed no significant change after treatment. In the PC group, PSA significantly increased after treatment. However, PSA decreased in the BPH/LUTS group. The alpha 1 blocker significantly improved urination status (the subjective symptoms and urodynamics parameters) in the BPH/LUTS group. In two groups, prostate volume showed no significant difference. Among those patients in the BPH/LUTS group, their urination status was significantly improved with alpha 1 blocker and their PSA level dropped slightly. On the other hand, the PSA level was significantly increased in the PC group. This study shows that by usingan alpha 1 blocker, it may be possible to avoid conductingthe prostate biopsy at an early stage or indeed one may not be needed at all for patients with only slight increases in PSA.
著作権等: 許諾条件により本文は2010-05-01に公開
URI: http://hdl.handle.net/2433/74777
PubMed ID: 19462822
出現コレクション:Vol.55 No.4

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。